PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmcphBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Public Health
 
BMC Public Health. 2012; 12: 778.
Published online Sep 13, 2012. doi:  10.1186/1471-2458-12-778
PMCID: PMC3491000
Remission of screen-detected metabolic syndrome and its determinants: an observational study
Corine den Engelsen,corresponding author1 Kees J Gorter,1 Philippe L Salomé,2 Maureen van den Donk,1 and Guy E Rutten1
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Huispostnr STR.6.131, P.O. Box 85500, 3508 GA, Utrecht, Netherlands
2Huisartsenzorg IJsselstein, locatie 't Steyn, Eiteren 15, 3401 PS, IJsselstein, Netherlands
corresponding authorCorresponding author.
Corine den Engelsen: c.denengelsen-2/at/umcutrecht.nl; Kees J Gorter: k.j.gorter/at/umcutrecht.nl; Philippe L Salomé: p.salome/at/hetnet.nl; Maureen van den Donk: m.vandendonk/at/nhg.org; Guy E Rutten: g.e.h.m.rutten/at/umcutrecht.nl
Received January 30, 2012; Accepted September 10, 2012.
Abstract
Background
Early detection and treatment of the metabolic syndrome may prevent diabetes and cardiovascular disease. Our aim was to assess remission of the metabolic syndrome and its determinants after a population based screening without predefined intervention in the Netherlands.
Methods
In 2006 we detected 406 metabolic syndrome cases (The National Cholesterol Education Program’s Adult Treatment Panel III (NCEP ATP III) definition) among apparently healthy individuals with an increased waist circumference. They received usual care in a primary care setting. After three years metabolic syndrome status was re-measured. We evaluated which baseline determinants were independently associated with remission.
Results
The remission rate among the 194 participants was 53%. Baseline determinants independently associated with a remission were the presence of more than three metabolic syndrome components (OR 0.46) and higher levels of waist circumference (OR 0.91), blood pressure (OR 0.98) and fasting glucose (OR 0.60).
Conclusions
In a population with screen-detected metabolic syndrome receiving usual care, more than half of the participants achieved a remission after three years. This positive result after a relatively simple strategy provides a solid basis for a nation-wide implementation. Not so much socio-demographic variables but a higher number and level of the metabolic syndrome components were predictors of a lower chance of remission. In such cases, primary care physicians should be extra alert.
Keywords: Metabolic syndrome, Abdominal obesity, Screening, Cardiovascular risk, Primary care
Articles from BMC Public Health are provided here courtesy of
BioMed Central